Department of Anesthesiology

You are here

Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.

TitleAntagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.
Publication TypeJournal Article
Year of Publication2005
AuthorsKopman AF, Kopman DJ, Ng J, Zank LM
JournalJ Clin Anesth
Volume17
Issue1
Pagination30-5
Date Published2005 Feb
ISSN0952-8180
KeywordsAdult, Aged, Androstanols, Anesthesia Recovery Period, Anesthesia, General, Atracurium, Electric Stimulation, Female, Humans, Male, Middle Aged, Monitoring, Intraoperative, Neostigmine, Nerve Block, Neuromuscular Nondepolarizing Agents, Parasympathomimetics, Prospective Studies
Abstract

STUDY OBJECTIVE: The purpose of this study is to determine the incidence of significant (train-of-four [TOF] ratio <0.70), but clinically undetectable (TOF ratio >0.40), residual neuromuscular block after neostigmine antagonism of profound cisatracurium (CIS) or rocuronium (ROC) block.

DESIGN: Prospective, randomized, open-label study.

SETTING: University hospital.

PATIENTS: Forty ASA physical status I and II undergoing elective surgical procedures.

INTERVENTIONS: Anesthesia was induced with propofol 1.5 to 2.5 mg/kg IV plus fentanyl 2 to 4 mug/kg and maintained with N(2)O/desflurane plus narcotic supplementation. The electromyographic response of the adductor pollicis was recorded. Train-of-four stimulation was given every 20 seconds. Twitch height (T1) and TOF fade ratio were continuously recorded. In group 1 (n = 20), neuromuscular block was induced with CIS 0.10 mg/kg, and T1 was maintained at 5% of control by a constant infusion of CIS until the end of surgery. One minute after the termination of the infusion, neostigmine 0.05 mg/kg was administered. T1 and TOF values were monitored continuously for the next 20 minutes. Group 2 (n = 20) is identical to group 1 except that the initial drug was ROC 0.60 mg/kg, and paralysis was maintained with an infusion of ROC.

MEASUREMENTS AND MAIN RESULTS: There were no significant differences in the recovery patterns of CIS vs ROC. The duration (bolus to end of infusion) in both groups averaged 2.7 hours, and the mean cumulative dose of relaxant approximated 4 x the ED(95). T1 at the time of reversal was 6% (4%-10%) of control. Mean TOF ratios at 10, 15, and 20 minutes were 0.55, 0.71, and 0.0.81, respectively. Return to a TOF ratio >0.40 was always achieved in 15 minutes or less. However, at 20 minutes postreversal, 5 of 40 subjects had TOF ratios <0.70 and only 11 individuals had recovered to a TOF ratio of 0.90 or greater.

CONCLUSIONS: Most clinicians cannot detect tactile fade once the TOF ratio exceeds 0.40. When reversing profound block, an objective monitor of neuromuscular function is required if the extent of residual block is to be assessed with any confidence.

DOI10.1016/j.jclinane.2004.03.009
Alternate JournalJ Clin Anesth
PubMed ID15721727